These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38448194)

  • 1. [Research progress on dyslipidemia related to human immunodeficiency virus infection].
    Li L; Ma P
    Zhonghua Nei Ke Za Zhi; 2024 Mar; 63(3):303-309. PubMed ID: 38448194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dyslipidemia in HIV patients.
    Tungsiripat M; Aberg JA
    Cleve Clin J Med; 2005 Dec; 72(12):1113-20. PubMed ID: 16392725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dyslipidemia and cardiovascular risk in human immunodeficiency virus infection.
    Kelesidis T; Currier JS
    Endocrinol Metab Clin North Am; 2014 Sep; 43(3):665-84. PubMed ID: 25169560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of clinical and therapeutic factors with incident dyslipidemia in a cohort of human immunodeficiency virus-infected and non-infected adults: 1994-2011.
    Tripathi A; Jerrell JM; Liese AD; Zhang J; Rizvi AA; Albrecht H; Duffus WA
    Metab Syndr Relat Disord; 2013 Dec; 11(6):417-26. PubMed ID: 23909647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical management considerations for dyslipidemia in HIV-infected individuals.
    Kirchner JT
    Postgrad Med; 2012 Jan; 124(1):31-40. PubMed ID: 22314112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV and its relationship to insulin resistance and lipid abnormalities.
    Non LR; Escota GV; Powderly WG
    Transl Res; 2017 May; 183():41-56. PubMed ID: 28068521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe weight gain, lipodystrophy, dyslipidemia, and obstructive sleep apnea in a human immunodeficiency virus-infected patient following highly active antiretroviral therapy.
    Dorey-Stein Z; Amorosa VK; Kostman JR; Lo Re V; Shannon RP
    J Cardiometab Syndr; 2008; 3(2):111-4. PubMed ID: 18453812
    [No Abstract]   [Full Text] [Related]  

  • 8. Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy.
    Wohl DA; McComsey G; Tebas P; Brown TT; Glesby MJ; Reeds D; Shikuma C; Mulligan K; Dube M; Wininger D; Huang J; Revuelta M; Currier J; Swindells S; Fichtenbaum C; Basar M; Tungsiripat M; Meyer W; Weihe J; Wanke C
    Clin Infect Dis; 2006 Sep; 43(5):645-53. PubMed ID: 16886161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyslipidemia in Human Immunodeficiency Virus Disease: JACC Review Topic of the Week.
    Kalra DK; Vorla M; Michos ED; Agarwala A; Virani S; Duell PB; Raal FJ
    J Am Coll Cardiol; 2023 Jul; 82(2):171-181. PubMed ID: 37407116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid management in human immunodeficiency virus.
    Myerson M
    Cardiol Clin; 2015 May; 33(2):277-98. PubMed ID: 25939300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular dysfunction in human immunodeficiency virus infection.
    Cade WT
    J Cardiometab Syndr; 2008; 3(2):83-7. PubMed ID: 18453807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Immunodeficiency Virus Infection, Antiretroviral Therapy, and Statin: a Clinical Update.
    Zanetti HR; Roever L; Gonçalves A; Resende ES
    Curr Atheroscler Rep; 2018 Feb; 20(2):9. PubMed ID: 29423787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of dyslipidemia in patients with human immunodeficiency virus.
    Shalit P
    Rev Cardiovasc Med; 2014; 15 Suppl 1():S38-46. PubMed ID: 24987862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation and pharmacologic management of the HIV-infected patient with dyslipidemia.
    Hardwicke RL; Lewis ST; Grimes RM
    J Assoc Nurses AIDS Care; 2010; 21(5):429-38. PubMed ID: 20303794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular disease in HIV infection.
    Sánchez-Torres RJ; García-Palmieri MR
    P R Health Sci J; 2006 Sep; 25(3):249-54. PubMed ID: 17203795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutritional therapy to prevent dyslipidemia in patients starting antiretroviral therapy for human immunodeficiency virus.
    Stein JH
    J Am Coll Cardiol; 2012 Mar; 59(11):989-90. PubMed ID: 22402069
    [No Abstract]   [Full Text] [Related]  

  • 17. Nonalcoholic Fatty Liver Disease and the Development of Metabolic Comorbid Conditions in Patients With Human Immunodeficiency Virus Infection.
    Krahn T; Martel M; Sapir-Pichhadze R; Kronfli N; Falutz J; Guaraldi G; Lebouche B; Klein MB; Wong P; Deschenes M; Ghali P; Sebastiani G
    J Infect Dis; 2020 Aug; 222(5):787-797. PubMed ID: 32249283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary intervention prevents dyslipidemia associated with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected individuals: a randomized trial.
    Lazzaretti RK; Kuhmmer R; Sprinz E; Polanczyk CA; Ribeiro JP
    J Am Coll Cardiol; 2012 Mar; 59(11):979-88. PubMed ID: 22402068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-associated dyslipidemia: pathogenesis and its management.
    Wan Z; Dai B; Zhu X; Huang Y; Zhu B
    Chin Med J (Engl); 2023 Nov; 136(22):2732-2734. PubMed ID: 37881960
    [No Abstract]   [Full Text] [Related]  

  • 20. HIV and highly active antiretroviral therapy: dyslipidemia, metabolic aberrations, and cardiovascular risk.
    Zou W; Berglund L
    Prev Cardiol; 2007; 10(2):96-103; quiz 104-5. PubMed ID: 17392622
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.